Evidence map›Paper›PMID 39192292›Full record

ArticleEpigenetics & chromatin2024

The role of hexokinases in epigenetic regulation: altered hexokinase expression and chromatin stability in yeast.

Srinivasu Karri, Quinn Dickinson, Jing Jia, Yi Yang, Haiyun Gan, Zhiquan Wang, Yibin Deng, Chuanhe Yu

Abstract read
In one paragraph

Article in Epigenetics & chromatin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Hydralazine potentiates the antiproliferative effect of photodynamic therapy on Candida albicans and Candida parapsilosis in vitro.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Comparative adaptability of 307Frontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Srinivasu KarriHormel Institute, University of Minnesota, Austin, MN, 55912, USA.
Quinn DickinsonHormel Institute, University of Minnesota, Austin, MN, 55912, USA.
Jing JiaHormel Institute, University of Minnesota, Austin, MN, 55912, USA.
Yi YangHormel Institute, University of Minnesota, Austin, MN, 55912, USA.
Haiyun GanCAS Key Laboratory of Quantitative Engineering Biology, Guangdong Provincial Key Laboratory of Synthetic Genomics and Shenzhen Key Laboratory of Synthetic Genomics, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Zhiquan WangDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Yibin DengDepartment of Urology, Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, MN, USA.
Chuanhe YuHormel Institute, University of Minnesota, Austin, MN, 55912, USA. yu000479@umn.edu.

Funding

Role of nucleosome dynamics in epigenetic inheritanceR01GM130588 · NIGMS · UNIVERSITY OF MINNESOTA · PI YU, CHUANHE · 2019 to 2023
$1.7M
National Natural Science Foundation of China Grants No. 32090031, 32070610NIGMS NIH HHS R01 GM130588NIGMS NIH HHS R01GM130588
6 · The paper itself

Abstract

backgroundHuman hexokinase 2 (HK2) plays an important role in regulating Warburg effect, which metabolizes glucose to lactate acid even in the presence of ample oxygen and provides intermediate metabolites to support cancer cell proliferation and tumor growth. HK2 overexpression has been observed in various types of cancers and targeting HK2-driven Warburg effect has been suggested as a potential cancer therapeutic strategy. Given that epigenetic enzymes utilize metabolic intermediates as substrates or co-factors to carry out post-translational modification of histones and nucleic acids modifications in cells, we hypothesized that altering HK2 expression could impact the epigenome and, consequently, chromatin stability in yeast. To test this hypothesis, we established genetic models with different yeast hexokinase 2 (HXK2) expression in Saccharomyces cerevisiae yeast cells and investigated the effect of HXK2-dependent metabolism on parental nucleosome transfer, a key DNA replication-coupled epigenetic inheritance process, and chromatin stability.

resultsBy comparing the growth of mutant yeast cells carrying single deletion of hxk1Δ, hxk2Δ, or double-loss of hxk1Δ hxk2Δ to wild-type cells, we firstly confirmed that HXK2 is the dominant HXK in yeast cell growth. Surprisingly, manipulating HXK2 expression in yeast, whether through overexpression or deletion, had only a marginal impact on parental nucleosome assembly, but a noticeable trend with decrease chromatin instability. However, targeting yeast cells with 2-deoxy-D-glucose (2-DG), a clinical glycolysis inhibitor that has been proposed as an anti-cancer treatment, significantly increased chromatin instability.

conclusionOur findings suggest that in yeast cells lacking HXK2, alternative HXKs such as HXK1 or glucokinase 1 (GLK1) play a role in supporting glycolysis at a level that adequately maintains epigenomic stability. While our study demonstrated an increase in epigenetic instability with 2-DG treatment, the observed effect seemed to occur dependent on non-glycolytic function of Hxk2. Thus, additional research is needed to identify the molecular mechanism through which 2-DG influences chromatin stability.

Indexed as

ChromatinEpigenesis, GeneticHexokinaseSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsGene Expression Regulation, FungalNucleosomesChromatinHexokinaseHXK2 protein, S cerevisiaeNucleosomesSaccharomyces cerevisiae Proteins2-deoxy-D-glucoseChromatin replicationChromatin stabilityeSPANHexokinaseHistone acetylationHistone chaperonesHistone methylationYeast

Identifiers

PMID39192292
PMCPMC11348520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.